Relay Therapeutics Inc — Balance Sheet (NASDAQ:RLAY) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Total assets 799.83 M1.01 B1.1 B843.98 M871.3 M621.33 M Total liabilities 36.54 M110.64 M149.55 M91.98 M93.5 M54.27 M Total equity 763.29 M897.81 M950.22 M752 M777.79 M567.06 M Total liabilities & shareholders' equities 799.83 M1.01 B1.1 B843.98 M871.3 M621.33 M Total debt —————— Net debt ——————

News

Relay Therapeutics stock hits 52-week high at 9.64 USD

Relay earnings beat by $0.09, revenue topped estimates

Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates

Relay Therapeutics earnings in spotlight after FDA breakthrough

Relay earnings in focus as FDA breakthrough fuels optimism

Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status

FDA grants breakthrough therapy status to Relay’s breast cancer drug

Relay Therapeutics president sells $166k in RLAY stock

Rahmer Peter, chief corporate development officer at Relay Therapeutics, sells $100k in shares

Oppenheimer Upgrade Fuels Relay Therapeutics Rally On Zovegalisib Optimism (NASDAQ:RLAY)

Relay Therapeutics stock rises after Oppenheimer upgrade

Oppenheimer upgrades Relay Therapeutics stock rating on gedatolisib concerns